‼️ New #ComboMATCH updates are enhancing patient care: ctDNA-based screening and progression biopsy results returned to treating physicians to inform future treatment decisions, advancing #PrecisionOncology for patients with specific DNA alterations. More ➡️ bit.ly/46Vdbug

Building on the success of NCI-MATCH, the #ComboMATCH #PrecisionMedicine initiative will test new drug combos for patients whose tumors have specific gene abnormalities, regardless of #cancer type. More: bit.ly/ComboMATCH